Publications by authors named "Xin-Guo"

6 Publications

  • Page 1 of 1

PLCε1 mediates one-lung ventilation injury by regulating the p38/RhoA/NFκB activation loop.

Mol Immunol 2021 May 1;133:135-145. Epub 2021 Mar 1.

Department of Anesthesiology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, No 157 Jinbi Rd, Kunming, 650032, China. Electronic address:

Background: Phospholipase C epsilon-1 (PLCε1) might be a novel and potential target in treating inflammatory conditions. In the present study, we aimed to clarify whether PLCε1 is involved in lung injury caused by one-lung ventilation (OLV) and to elucidate the potential molecular mechanism of PLCε1-mediated signaling pathway on OLV induced inflammatory response and injury.

Methods: Male Sprague-Dawley (SD) rats were divided into wide-type (PLCε1-WT) group and PLCε1-KO group, and were treated with OLV for 0.5 h, 1 h, and 2 h respectively. Observation of lung tissue injury in rats was performed by Hematoxylin and eosin (HE) staining and Wet/dry (W/D) radios. In addition, pulmonary microvascular endothelial cells (PMVECs) transfected with PLCε1-si RNA, were stimulated by lipopolysaccharide (LPS). To explore the possible roles of PLCε1 in the OLV induced inflammatory injury and the involved pathway underlying, the lung tissue and bronchoalveolar lavage fluids (BALF) of OLV rats, as well as the PMVECs were prepared for further analysis. Enzyme-linked immunoassay (ELISA) was used to detect the expression of pro-inflammatory factors. The activities of related pathway proteins (NF-κB, phospho-p38, p38, phospho-ERK1/2, ERK1/2, RhoA and ROCK) were also detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blot analysis.

Results: Compared to the PLCε1-WT rats, PLCε1-KOrats exhibited marked alleviation of lung inflammation as shown by great reduction in lung wet/dry weight ratios, decreases in the expressions of pro-inflammatory mediators, and declines in the number of neutrophils and the protein concentration in bronchoalveolar lavage fluid (BALF). Moreover, the increased expressions of RhoA and NF-κB p65 mRNA induced by OLV were significantly inhibited in PLCε1-KO rats. In LPS treated PMVECs, PLCε1-si RNA transfection ones also showed the decrease expression of proinflammatory mediators, reduction in p38 phosphorylation levels and downregulation of RhoA/ROCK signaling activation. Co-cultured with PLCε1-si RNA and BTRB796 (p38 inhibitors) in LPS-stimulated PMVECs resulted in a significant reduction in RhoA and NF-κB activity. In addition, treatment with either ROCK inhibitor (Y-27632) or dominant negative mutant of RhoA (RhoT19 N) significantly reduced the expression of NF-κB in PLCε1-si RNA treated PMVECs.

Conclusion: The results indicated that PLCε1 played an important role in the inflammatory response induced by OLV. Moreover, through promoting p38/RhoA/ROCK activation loop, PLCε1 promoted NF-κB activation and thereby increased the expressions of inflammatory mediators, which induced the PMVECs inflammation and subsequent injury. The results of this study provide a potential therapeutic target for the reduction of inflammatory response in patients with OLV.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2021.02.013DOI Listing
May 2021

A new EMG-based index towards the assessment of elbow spasticity for post-stroke patients.

Annu Int Conf IEEE Eng Med Biol Soc 2017 Jul;2017:3640-3643

The commonly used method for grading spasticity in clinical applications is Modified Ashworth Scale (MAS). The MAS-based method depends on the subjective evaluations and the experience of physicians, which may lead to imprecise and inconsistent evaluations. In this study, we propose a novel index (A-ApA, which was calculated with the root mean square (RMS) of agonist muscle activity by the mean between the RMS of agonistic and antagonistic muscle activations extracted from surface electromyography (sEMG) signals to quantitatively assess elbow spasticity. 39 post-stroke patients with elbow spasticity caused by hemiplegia participated in the experiments, and their elbow spasticity was assessed with MAS by one experienced physiotherapist. Patients were thereafter divided into four groups according to the MAS scales. The sEMG signals were recorded simultaneously on the patients' biceps and triceps when they extended or bended their elbows passively. The correlations between MAS and RMS of sEMG signals as well as the newly proposed index were calculated. The results demonstrated that the correlation between the MAS and the sEMG-based index in the assessment of elbow spasticity was significant. This suggests that the EMG-based index would be helpful for the assessment of spasticity..
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC.2017.8037646DOI Listing
July 2017

A study of feature extraction for Alzheimer's disease based on resting-state fMRI.

Annu Int Conf IEEE Eng Med Biol Soc 2017 Jul;2017:517-520

The Alzheimer's Disease (AD) has become a major threat of human health with its incidence rate ascending year by year. Early diagnosis of AD is very important for AD patients to keep life quality. The resting-state fMRI (rs-fMRI) which precisely reflects the brain changes on the resting state of individuals provides a quantitative approach, which has been introduced to distinguish AD patients from normal population. In this study, we proposed a method to find the most distinctive features identifying AD patients from rs-fMRI images. The ALFF and ReHo parameters based on pre-processed rs-fMRI data were extracted, and some key parameters of the brain functional network based on graph theory were calculated. Then we tested the recognition performance of different classifiers, and the best classification algorithm, that is, Support Vector Machine (SVM) with linear-kernel are selected. Finally through a recursive feature selection procedure, we got the most distinctive feature set. Additionally, this study also implies that there may be several changes in some particular ROIs of the brain during the AD development.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC.2017.8036875DOI Listing
July 2017

Pharmacokinetics and pharmacodynamics of a novel Acetylcholinesterase Inhibitor, DMNG-3.

Acta Neurobiol Exp (Wars) 2016 ;76(2):117-24

School of Life Science and Engineering, Lanzhou University of Technology, Key Laboratory of screening for and Deep processing in new Tibetan medicine of Gansu Province, Gansu, P.R. China.

DMNG-3(3β-Methyl-[2-(4-nitrophenoxy)ethyl]-amino]con-5-enine), is a new and the potentially most potent acetylcholinesterase inhibitor recently obtained from conessine by N-demethylation and nucleophilic substitution reaction. In the present study, a step-down passive avoidance test was used to investigate whether DMNG-3 could modulate impairment of learning and memory induced by scopolamine, and a high performance liquid chromatography(HPLC) method for the determination of DMNG-3 in biological samples was applied to study its pharmacokinetics and tissues distribution. Separation was achieved on C18 column using a mobile phase consisting methanol-water (70:30, v/v) at a flow rate of 1.0ml/min. The intra- and inter-day precisions were good and the RSD was all lower than 1.30%. The mean absolute recovery of DMNG-3 in plasma ranged from 88.55 to 96.45 %. Our results showed oral administration of DMNG-3(10,25,50 mg/kg/day) can significantly improve the latency and number of errors and had a positive effect of improvement of learning and memory in mice in passive avoidance tests. The elimination half-life (T1/2) was 14.07±1.29, 15.87±1.03h, and the total clearance (CL) values were 0.70±0.11, 0.78±0.13 L/h/kg, respectively. The pharmacokinetic studies showed that DMNG-3 has a slowly clearance and large distribution volume in experimental animals, and its disposition is linear over the range of doses tested. The liver, small intestine, stomach, and large intestine were the major distribution tissues of DMNG-3 in mice. It was found that DMNG-3 could be detected in brain, suggesting that DMNG-3 can cross the blood-brain barrier. The present study shows that DMNG-3 can be possible developed as a new drug for the treatment of Alzheimer's disease in the future.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.21307/ane-2017-011DOI Listing
February 2017

Inhibition of EZH2 expression is associated with the proliferation, apoptosis and migration of SW620 colorectal cancer cells in vitro.

Exp Biol Med (Maywood) 2015 Apr 27;240(4):546-55. Epub 2015 Feb 27.

Epigenetic changes have been recently recognized as important in many human cancers. Enhancer of zeste homologue 2 (EZH2) gene has shown overexpression in various human cancers, consistent with a straightforward role of EZH2 as an oncogene, but its function in carcinogenesis is partly contradictory. The role of EZH2 in development of human colorectal cancer (CRC) has not yet been clarified. In present study, we observed up-regulation of EZH2 expression in tumor tissues from CRC patients. The expression of EZH2 in CRC cell lines is consistent with the trend in cancer tissues using RT-PCR. We showed that TNM stage and lymph node metastasis in CRC patients are significantly correlated with EZH2 expression levels. EZH2 level of transcription and protein was inhibited by small interfering RNA (siRNA). More importantly, EZH2-siRNA inhibited the proliferation and migration of SW620 cells while promoting their apoptosis, and inducing G0/G1 cell cycle arrest of CRC cells. Collectively, our results suggest that up-regulated EZH2 expression may contribute to the progression of the patients with CRC. A comprehensive study of epigenetic mechanisms and the relevance of EZH2 in CRC is important for fully understanding this disease and as a basis for developing new treatment options in patients with CRC.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1177/1535370215573463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935376PMC
April 2015

The comparative protective effects of ganoderma spores lipid and fish oil on N-methyl-N-nitrosourea-induced photoreceptor cell lesion in rats.

Evid Based Complement Alternat Med 2011 18;2011:903261. Epub 2011 May 18.

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, 54 Xianlie Road South, Guangzhou 510060, China.

Purpose. To compare Ganoderma spores lipid (GSL) and fish oil (FO) in inhibiting retinal photoreceptor cell lesions induced by N-methyl-N-nitrosourea (MNU) in rats. Methods. 120 rats were untreated (normal control, NC group) or treated with a single intraperitoneal injection of 40 mg/kg MNU (MNU group) then treated with GSL (GSL group) or FO (FO group). Eyes were obtained at 1, 3, 5, 7, and 10 days. Results. Light microscopy assay demonstrated that GSL and FO alleviated rat retinal photoreceptor cell damage (GSL and FO versus MNU group P < .001) similarly (GSL versus FO group P = .980). Electron microscopy confirmed that GSL and FO reversed damage to photoreceptor segments and photoreceptor cell nuclei. GSL-treated rats showed significantly elevated a-wave and b-wave amplitudes over MNU group (P < .05) but less than NC group (P < .05) and not significantly different from FO group (P > .05). Conclusion. GSL, like FO, alleviates rat retinal photoreceptor cell damage induced by MNU.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/903261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108162PMC
July 2011